# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001919246-26-000014
Filing Date
2026-03-19
Accepted
2026-03-19 06:39:22
Documents
42
Period of Report
2026-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | pths-20260319.htm iXBRL | 8-K | 32898
2 | EX-99.1 | pths-pressreleasex20250319.htm | EX-99.1 | 170793
3 | EX-99.2 | companypresentation_2026.htm | EX-99.2 | 32709
7 |  | companypresentation_2026001.jpg | GRAPHIC | 66427
8 |  | companypresentation_2026002.jpg | GRAPHIC | 249924
9 |  | companypresentation_2026003.jpg | GRAPHIC | 119445
10 |  | companypresentation_2026004.jpg | GRAPHIC | 165952
11 |  | companypresentation_2026005.jpg | GRAPHIC | 176133
12 |  | companypresentation_2026006.jpg | GRAPHIC | 51177
13 |  | companypresentation_2026007.jpg | GRAPHIC | 141358
14 |  | companypresentation_2026008.jpg | GRAPHIC | 113459
15 |  | companypresentation_2026009.jpg | GRAPHIC | 175736
16 |  | companypresentation_2026010.jpg | GRAPHIC | 112418
17 |  | companypresentation_2026011.jpg | GRAPHIC | 50648
18 |  | companypresentation_2026012.jpg | GRAPHIC | 81812
19 |  | companypresentation_2026013.jpg | GRAPHIC | 86533
20 |  | companypresentation_2026014.jpg | GRAPHIC | 109743
21 |  | companypresentation_2026015.jpg | GRAPHIC | 87342
22 |  | companypresentation_2026016.jpg | GRAPHIC | 53017
23 |  | companypresentation_2026017.jpg | GRAPHIC | 155469
24 |  | companypresentation_2026018.jpg | GRAPHIC | 54459
25 |  | companypresentation_2026019.jpg | GRAPHIC | 164466
26 |  | companypresentation_2026020.jpg | GRAPHIC | 49055
27 |  | companypresentation_2026021.jpg | GRAPHIC | 106473
28 |  | companypresentation_2026022.jpg | GRAPHIC | 142224
29 |  | companypresentation_2026023.jpg | GRAPHIC | 40207
30 |  | companypresentation_2026024.jpg | GRAPHIC | 122875
31 |  | companypresentation_2026025.jpg | GRAPHIC | 113531
32 |  | companypresentation_2026026.jpg | GRAPHIC | 73585
33 |  | companypresentation_2026027.jpg | GRAPHIC | 159085
34 |  | companypresentation_2026028.jpg | GRAPHIC | 68152
35 |  | image.jpg | GRAPHIC | 15435
| Complete submission text file | 0001919246-26-000014.txt |  | 4672341

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | pths-20260319.xsd | EX-101.SCH | 1770
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | pths-20260319_lab.xml | EX-101.LAB | 23449
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | pths-20260319_pre.xml | EX-101.PRE | 13573
45 | EXTRACTED XBRL INSTANCE DOCUMENT | pths-20260319_htm.xml | XML | 2925

Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 26772344
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)